368 related articles for article (PubMed ID: 28549426)
21. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.
Branch OH; Udhayakumar V; Hightower AW; Oloo AJ; Hawley WA; Nahlen BL; Bloland PB; Kaslow DC; Lal AA
Am J Trop Med Hyg; 1998 Feb; 58(2):211-9. PubMed ID: 9502606
[TBL] [Abstract][Full Text] [Related]
24. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection.
Deloron P; Dubois B; Le Hesran JY; Riche D; Fievet N; Cornet M; Ringwald P; Cot M
Clin Exp Immunol; 1997 Nov; 110(2):212-8. PubMed ID: 9367404
[TBL] [Abstract][Full Text] [Related]
25. IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood.
Gbaguidi MLE; Adamou R; Edslev S; Hansen A; Domingo ND; Dechavanne C; Massougbodji A; Garcia A; Theisen M; Milet J; Donadi EA; Courtin D
Malar J; 2024 May; 23(1):154. PubMed ID: 38764069
[TBL] [Abstract][Full Text] [Related]
26. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.
Steketee RW; Wirima JJ; Bloland PB; Chilima B; Mermin JH; Chitsulo L; Breman JG
Am J Trop Med Hyg; 1996; 55(1 Suppl):42-9. PubMed ID: 8702036
[TBL] [Abstract][Full Text] [Related]
27. Studies on Plasmodium falciparum isotypic antibodies and numbers of IL-4 and IFN-gamma secreting cells in paired maternal cord blood from South West Cameroon.
Achidi EA; Anchang JK; Minang JT; Ahmadou MJ; Troye-Blomberg M
Int J Infect Dis; 2005 May; 9(3):159-69. PubMed ID: 15840457
[TBL] [Abstract][Full Text] [Related]
28. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
[TBL] [Abstract][Full Text] [Related]
29. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
Mahaman Moustapha L; Adamou R; Ibrahim ML; Abdoulaye Louis Padounou M; Diallo A; Courtin D; Testa J; Ndiaye JLA
Malar J; 2021 Jan; 20(1):1. PubMed ID: 33386070
[TBL] [Abstract][Full Text] [Related]
30. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.
Nhabomba AJ; Guinovart C; Jiménez A; Manaca MN; Quintó L; Cisteró P; Aguilar R; Barbosa A; Rodríguez MH; Bassat Q; Aponte JJ; Mayor A; Chitnis CE; Alonso PL; Dobaño C
Malar J; 2014 Mar; 13():121. PubMed ID: 24674654
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to Pf155/RESA and circumsporozoite protein of Plasmodium falciparum in paired maternal-cord sera from Nigeria.
Achidi EA; Perlmann H; Salimonu LS; Asuzu MC; Perlmann P; Berzins K
Parasite Immunol; 1995 Oct; 17(10):535-40. PubMed ID: 8587791
[TBL] [Abstract][Full Text] [Related]
32. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
[TBL] [Abstract][Full Text] [Related]
33. Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants.
Dechavanne C; Cottrell G; Garcia A; Migot-Nabias F
PLoS One; 2015; 10(12):e0145464. PubMed ID: 26698578
[TBL] [Abstract][Full Text] [Related]
34. Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo.
Francine N; Damien B; Anna F; Michael K; Christevy VJ; Felix KK
Acta Trop; 2016 Jan; 153():111-5. PubMed ID: 26477849
[TBL] [Abstract][Full Text] [Related]
35. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
[TBL] [Abstract][Full Text] [Related]
36. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
Aubouy A; Migot-Nabias F; Deloron P
Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
[TBL] [Abstract][Full Text] [Related]
37. [Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].
Diouf I; Tine RC; Ndiaye JL; Sylla K; Faye B; Mengue ML; Faye O; Dieng Y; Gaye A; Gaye O
Bull Soc Pathol Exot; 2011 Oct; 104(4):277-83. PubMed ID: 21818679
[TBL] [Abstract][Full Text] [Related]
38. HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya.
Odhiambo EO; Datta D; Guyah B; Ayodo G; Ondigo BN; Abong'o BO; John CC; Frosch AEP
Malar J; 2019 Aug; 18(1):297. PubMed ID: 31470903
[TBL] [Abstract][Full Text] [Related]
39. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
40. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
